Published in Aust N Z J Med on February 01, 1989
Treatment of advanced squamous cell carcinoma. Aust N Z J Med (1989) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol (1983) 4.35
Control of developmental transcription factor sigma F by sporulation regulatory proteins SpoIIAA and SpoIIAB in Bacillus subtilis. Proc Natl Acad Sci U S A (1990) 3.85
An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis. Cell (1994) 3.56
Energy balance and colon cancer--beyond physical activity. Cancer Res (1997) 3.11
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ (2001) 2.11
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
SpoIIE governs the phosphorylation state of a protein regulating transcription factor sigma F during sporulation in Bacillus subtilis. Proc Natl Acad Sci U S A (1996) 2.03
Combining tabular, rule-based, and procedural knowledge in computer-based guidelines for childhood immunization. Comput Biomed Res (1997) 1.94
Role of adenosine nucleotides in the regulation of a stress-response transcription factor in Bacillus subtilis. J Mol Biol (1996) 1.91
A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc (1994) 1.70
JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem (2000) 1.69
Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer (1993) 1.64
Specifications for equipment used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J (2000) 1.57
CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity (2001) 1.47
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother (2009) 1.35
Adenyl cyclase in cardiac tissue. J Biol Chem (1970) 1.32
The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis. Sex Transm Infect (2008) 1.30
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Support Care Cancer (1993) 1.23
The preparation of polyamide-oligonucleotide probes containing multiple non-radioactive labels. Nucleic Acids Res (1990) 1.20
On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol (1983) 1.17
On the receiving end. IV: Validation of quality of life indicators. Ann Oncol (1991) 1.16
Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun (1998) 1.15
Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect (2008) 1.15
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Ann Oncol (1993) 1.14
Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab (1995) 1.12
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11
Sexual behaviour, STDs and drug use in a crack house population. Int J STD AIDS (1999) 1.10
Effect of epinephrine on phosphorylase b kinase in perfused rat hearts. J Biol Chem (1966) 1.09
Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics (2013) 1.09
Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care (1996) 1.07
Measurement of respiratory system resistance by forced oscillation in normal children: a comparison with spirometric values. Pediatr Pulmonol (1991) 1.05
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group. Eur J Cancer (1992) 1.03
Evidence for common sites of contact between the antisigma factor SpoIIAB and its partners SpoIIAA and the developmental transcription factor sigmaF in Bacillus subtilis. J Mol Biol (1998) 1.02
Definition of COPD: based on evidence or opinion? Eur Respir J (2008) 1.01
The kinase activity of the antisigma factor SpoIIAB is required for activation as well as inhibition of transcription factor sigmaF during sporulation in Bacillus subtilis. J Mol Biol (1998) 1.00
The synthesis of polyamide-oligonucleotide conjugate molecules. Nucleic Acids Res (1990) 0.98
Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. Br J Cancer (1998) 0.97
IFN-gamma and LPS-mediated IL-10-dependent suppression of retinal microglial activation. Invest Ophthalmol Vis Sci (2000) 0.97
Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action. Mol Psychiatry (2005) 0.96
Adenyl cyclase. Kinetic properties and nature of fluoride and hormone stimulation. J Biol Chem (1971) 0.95
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group. Eur J Cancer (1998) 0.94
Cerebral metastases from malignant melanoma. Radiother Oncol (1992) 0.94
Promoting smoking cessation in general practice. BMJ (1993) 0.94
Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin. J Virol (1988) 0.94
Psychopathology in young adults born at extremely low birth weight. Psychol Med (2010) 0.93
The National Breast Screening Study: pre-recruitment sources of awareness in participants. Can J Public Health (1989) 0.91
Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation. Clin Exp Allergy (2004) 0.90
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Ann Oncol (1997) 0.89
IMM/Serve: a rule-based program for childhood immunization. Proc AMIA Annu Fall Symp (1996) 0.89
Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family? Curr Top Microbiol Immunol (2000) 0.89
Aminoglutethimide in advanced prostatic carcinoma. Br J Urol (1987) 0.89
Plant foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control (1997) 0.88
Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates. Cancer Immunol Immunother (1987) 0.87
Women gain weight 1 year after smoking cessation while dietary intake temporarily increases. J Am Diet Assoc (1996) 0.87
Chemical synthesis of 10 kDa chaperonin. Biological activity suggests chaperonins do not require other molecular chaperones. FEBS Lett (1991) 0.87
A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Res (2001) 0.87
Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen. J Autoimmun (1999) 0.87
Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol (2004) 0.87
Deep Impact: observations from a worldwide Earth-based campaign. Science (2005) 0.87
Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction. Br J Ophthalmol (2001) 0.85
Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism. Cell Immunol (1974) 0.85
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Ann Oncol (2008) 0.85
Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo. Br J Psychiatry (1981) 0.85
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group. Ann Oncol (1994) 0.84
Dietary energy sources and colon cancer risk. Am J Epidemiol (1997) 0.84
Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer. J Clin Oncol (1999) 0.83
Globin gene transcripts can utilize histone gene 3' end processing signals. Nucleic Acids Res (1986) 0.83
Central and peripheral adverse hemodynamic changes during laparoscopic surgery and their reversal with a novel intermittent sequential pneumatic compression device. Ann Surg (2001) 0.83
Chemotherapy for metastatic breast cancer--when is enough enough? Eur J Cancer (1997) 0.82
Regional differences in the sympathetic innervation of the guinea pig large intestine by neuropeptide Y- and tyrosine hydroxylase-immunoreactive nerves of divergent extrinsic origin. J Comp Neurol (1999) 0.81
Purification and Characterization of a Population of EGFP-Expressing Cells from the Developing Pancreas of a Neurogenin3/EGFP Transgenic Mouse. Organogenesis (2005) 0.81
Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. J Clin Oncol (1993) 0.81
Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant. Arch Dis Child (2003) 0.80
Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant (1999) 0.80
Postsurgical dermal lymphedema clinically mimicking inflammatory breast carcinoma. Arch Dermatol (2001) 0.80
Perceptions of human immunodeficiency virus and sexually transmitted disease risk among low-income adults: a pilot study. Appl Nurs Res (2001) 0.80
Transcription of cloned transfer RNA genes from Drosophila melanogaster in a homologous cell-free extract. Nucleic Acids Res (1982) 0.79
Experimental vesicular stomatitis virus infection in horses: effect of route of inoculation and virus serotype. Vet Pathol (2006) 0.79
Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response. Br J Ophthalmol (2005) 0.79
Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma. J Interferon Res (1986) 0.79
Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion. Cancer Chemother Pharmacol (1986) 0.79
Activation of cardiac phosphorylase b kinase. J Biol Chem (1966) 0.78
Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Invest Ophthalmol Vis Sci (1999) 0.78
On the mechanism of activation of phosphorylase b kinase by calcium. J Biol Chem (1968) 0.78
Hypertrophy of the internal oblique abdominal muscle of ewes bred intensively. J Comp Pathol (1978) 0.78
Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma. Cancer (1986) 0.77
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group. Eur J Cancer (1997) 0.77
Partial purification of stable transcription complexes with cloned tRNA genes of Drosophila melanogaster. J Biol Chem (1985) 0.77
Standardisation of lung function testing: the authors' replies to readers' comments. Eur Respir J (2010) 0.77
The action of calcium ion on cardiac phosphorylase b kinase. J Biol Chem (1966) 0.76
Ex vivo adenovirus mediated gene transfection of human conjunctival epithelium. Br J Ophthalmol (2001) 0.76